Bristol-Myers Squibb shares are trading lower after multiple analysts downgraded the stock. The company on Thursday reported mixed Q3 financial results.
Portfolio Pulse from Benzinga Newsdesk
Bristol-Myers Squibb's shares are trading lower following mixed Q3 financial results and subsequent downgrades by multiple analysts.
October 27, 2023 | 3:48 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bristol-Myers Squibb's stock is trading lower due to mixed Q3 results and analyst downgrades.
Bristol-Myers Squibb's Q3 results were mixed, which is generally not well-received by the market. Additionally, multiple analysts downgraded the stock, which can lead to a decrease in investor confidence and a subsequent drop in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100